U.S., May 31 -- ClinicalTrials.gov registry received information related to the study (NCT06996782) titled 'A Platform Study in Non-Small Cell Lung Cancer (NSCLC)' on May 05.
Brief Summary: The purpose of this study is to assess the safety and efficacy of multiple study interventions including novel-novel combinations or novel agents in combination with standard therapy for the treatment of metastatic NSCLC.
Study Start Date: May 23
Study Type: INTERVENTIONAL
Condition:
Advanced or Metastatic Non-small Cell Lung Cancer
Intervention:
BIOLOGICAL: Rilvegostomig
Rilvegostomig will be administered as an intravenous (IV) infusion.
BIOLOGICAL: AB248
AB248 will be administered via syringe or an IV bag.
DRUG: Cisplatin
Cisplatin will be ...